Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Daniel S. Metzinger"'
Autor:
Garrett L. Jensen, Parul N. Barry, Harriet Eldredge-Hindy, Scott R. Silva, Sarah L. Todd, Kendall P. Hammonds, Walker R. Zimmerman, Daniel S. Metzinger, Moataz N. El-Ghamry
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 13, Iss 3, Pp 294-301 (2021)
Externí odkaz:
https://doaj.org/article/dd0e204d20aa4171a7fd0fcdb6e3ae9f
Publikováno v:
Case Reports in Obstetrics and Gynecology, Vol 2012 (2012)
Adenomyomas are benign tumors composed of smooth muscle and endometrial tissue. These tumors usually arise from the myometrium. Extrauterine adenomyomas are rare with only a few case reports available in the literature. Here, we report an unusual cas
Externí odkaz:
https://doaj.org/article/9c409823eefa40b3a37fc315f1e3eaf8
Autor:
Harriet B Eldredge-Hindy, Daniel S Metzinger, Sarah L Todd, Matthew R Nichols, Scott R Silva, Jeremy T Gaskins
Publikováno v:
Southern Medical Journal. 114:630-635
OBJECTIVES The objective of this analysis was to gauge how the incidence and mortality of uterine cancer in Kentucky have changed from 1995 through 2017. An assessment of the trends in incidence and mortality across different geographic areas and bet
Autor:
Kendall Hammonds, Daniel S. Metzinger, Garrett L Jensen, Harriet Eldredge-Hindy, Walker R. Zimmerman, Parul Barry, Sarah L. Todd, Scott R. Silva, M.N. El-Ghamry
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 13, Iss 3, Pp 294-301 (2021)
Journal of Contemporary Brachytherapy
Journal of Contemporary Brachytherapy
Purpose American Brachytherapy Society (ABS) guidelines recommend using a 3-5 cm active length (AL) when treating vaginal cuff (VC) in adjuvant setting of endometrial cancer (EC). The purpose of this study was to evaluate local control and toxicity,
Autor:
Leonid B. Reshko, Daniel S. Metzinger, Harriet B Eldredge-Hindy, Sarah L. Todd, Jeremy Gaskins, Scott R. Silva, Sara M. Dryden
Publikováno v:
International Journal of Gynecologic Cancer. 31:694-701
BackgroundThe optimal treatment of patients with FIGO stage IB grade 3 endometrial endometrioid adenocarcinoma remains unknown.ObjectiveTo compare overall survival following treatment with a hysterectomy and adjuvant radiotherapy with or without chem
Autor:
Daniel S. Metzinger, Sarah L. Todd, Harriet Eldredge-Hindy, Matthew R. Nichols, Jeremy Gaskins, Scott R. Silva
Publikováno v:
Gynecologic Oncology. 158:446-451
The goal of this study was to assess how the incidence and mortality of cervical cancer in Kentucky has changed from 1995 through 2017. Additionally, trends in incidence and mortality across different geographic areas and between different races were
Autor:
Harriet Eldredge-Hindy, Jeremy Gaskins, Sarah L. Todd, Daniel S. Metzinger, Scott R. Silva, Leonid B. Reshko, Sara M. Dryden
Publikováno v:
Gynecologic Oncology. 162:S303-S304
Objectives: The optimal treatment of FIGO stage IB grade 3 endometrial endometrioid adenocarcinoma remains unknown. It is unclear if adjuvant chemotherapy (CHT) in addition to adjuvant radiotherapy enhances survival in this subgroup of endometrial ca
Autor:
Sarah L. Todd, Daniel S. Metzinger, Scott R. Silva, Leonid B. Reshko, Jeremy Gaskins, Harriet Eldredge-Hindy
Publikováno v:
Brachytherapy. 20(1)
Purpose Vaginal cancer is a rare tumor that is optimally treated with a combination of chemotherapy (CHT) and radiation therapy. Because of the rarity of this cancer, the benefit of a brachytherapy boost (BT) and the relevance of radiotherapy time to
Autor:
Neal Bhatt, Jeremy Gaskins, Ashley Amsbaugh, Daniel S. Metzinger, Lynn P. Parker, Thomas Hunter, Keith Sowards, M.N. El-Ghamry, Mark J. Amsbaugh
Publikováno v:
Brachytherapy. 15:49-56
Purpose To identify dosimetric predictors of outcome and toxicity in patients receiving CT-planned interstitial brachytherapy (ISBT) for gynecologic cancers. Methods and Materials Patients who received ISBT between 2009 and 2014 were reviewed. Demogr
Autor:
Neal Bhatt, Ashley Amsbaugh, M.N. El-Ghamry, Daniel S. Metzinger, Keith Sowards, Thomas Hunter, Jeremy Gaskins, Lynn P. Parker, Mark J. Amsbaugh
Publikováno v:
Brachytherapy. 14:600-605
Purpose To report outcomes and identify predictors of toxicity in patients undergoing reirradiation with interstitial brachytherapy (ISBT) for recurrent cancers of the female reproductive tract. Methods and Materials Twenty-one patients received ISBT